Insider Trading activities of Voyager Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Voyager Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Voyager Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Voyager Therapeutics, Inc. since 2005. The reporting company's ticker symbol is VYGR. The reporting company's CIK number is 1640266.
The total value of stock buying since 2005 is $52,098,075.
The total value of stock sales since 2005 is $2,349,230.
The total value of stock option exercises since 2005 is $729,988.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Voyager Therapeutics, Inc. (VYGR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-03 4,179,728 $50,002,086 0 $0 0 $0
2018-09 8,000 $150,370 0 $0 0 $0
2018-08 3,000 $54,929 0 $0 0 $0
2018-04 0 $0 2,451 $45,049 0 $0
2018-03 0 $0 50,867 $1,093,592 48,416 $579,539
2018-02 0 $0 18,074 $513,396 15,623 $150,449
2018-01 0 $0 3,630 $59,531 0 $0
2017-12 0 $0 5,490 $74,828 0 $0
2017-11 0 $0 5,490 $72,797 0 $0
2017-10 0 $0 10,980 $223,223 0 $0
2017-09 0 $0 16,470 $211,914 0 $0
2017-07 0 $0 5,490 $54,900 0 $0
2016-01 10,000 $140,690 0 $0 0 $0
2015-11 125,000 $1,750,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Voyager Therapeutics, Inc. insiders (VYGR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-03-12 Neurocrine Biosciences Inc (10% Owner) Buy 4,179,728 11.96 50,002,086
2018-09-12 Pierce Glenn (Director) Buy 5,000 18.44 92,200
2018-09-10 Geraghty James A (Director) Buy 3,000 19.39 58,170
2018-08-17 Geraghty James A (Director) Buy 3,000 18.31 54,929
2018-04-10 Ravina Bernard (Chief Medical Officer) Sale 2,451 18.38 45,049
2018-03-23 Henderson Jane (Sr. V.P. & CFO, Corp. Dev.) Sale 11,200 20.52 229,824
2018-03-23 Henderson Jane (Sr. V.P. & CFO, Corp. Dev.) Option Ex 11,200 11.97 134,064
2018-03-22 Henderson Jane (Sr. V.P. & CFO, Corp. Dev.) Sale 19,900 21.07 419,293
2018-03-22 Henderson Jane (Sr. V.P. & CFO, Corp. Dev.) Option Ex 19,900 11.97 238,203
2018-03-19 Henderson Jane (CFO & SVP, Corp. Dev.) Sale 1,900 21.76 41,344
2018-03-19 Henderson Jane (CFO & SVP, Corp. Dev.) Option Ex 1,900 11.97 22,743
2018-03-16 Henderson Jane (CFO & SVP, Corp. Dev.) Sale 15,416 22.15 341,464
2018-03-16 Henderson Jane (CFO & SVP, Corp. Dev.) Option Ex 15,416 11.97 184,529
2018-03-12 Ravina Bernard (Chief Medical Officer) Sale 2,451 25.16 61,667
2018-02-27 Sah Dinah Ph.d. (Chief Scientific Officer) Sale 15,623 30.00 468,690
2018-02-27 Sah Dinah Ph.d. (Chief Scientific Officer) Option Ex 15,623 9.63 150,449
2018-02-12 Ravina Bernard (Chief Medical Officer) Sale 2,451 18.24 44,706
2018-01-10 Ravina Bernard (Chief Medical Officer) Sale 3,630 16.40 59,531
2017-12-11 Ravina Bernard (Chief Medical Officer) Sale 5,490 13.63 74,828
2017-11-10 Ravina Bernard (Chief Medical Officer) Sale 5,490 13.26 72,797
2017-10-10 Ravina Bernard (Chief Medical Officer) Sale 10,980 20.33 223,223
2017-09-11 Ravina Bernard (Chief Medical Officer) Sale 10,980 14.30 157,014
2017-09-05 Ravina Bernard (Chief Medical Officer) Sale 5,490 10.00 54,900
2017-07-20 Ravina Bernard (Chief Medical Officer) Sale 5,490 10.00 54,900
2016-01-14 Paul Steven M (President and CEO) Buy 10,000 14.07 140,690
2015-11-16 Sanofi (Other) Buy 125,000 14.00 1,750,000

Insider trading activities including stock purchases, stock sales, and option exercises of VYGR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Voyager Therapeutics, Inc. (symbol VYGR, CIK number 1640266) see the Securities and Exchange Commission (SEC) website.